Angelo Lombardo (Ph.D.) is Professor of tissue biology and regenerative medicine at the Vita-Salute San Raffaele University and Group Leader at the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget), Milan, IT. His research activities revolve around the development and application of genome and epigenome editing technologies. Angelo is also co-founder of Chroma Medicine Inc. (Boston, USA), a start-up that aims to develop new gene therapy modalities based on targeted epigenetic editing.